DarrellMealerWilsonMD

Pediatric Endocrinology • Stanford, CA

Professor, Pediatrics - Endocrinology and Diabetes, Stanford University Medical Center

Join to view full profile

Dr. Wilson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wilson's full profile

Already have an account?

Office
300 Pasteur Dr
G 313 Med Center Mc 5208
Stanford, CA 94305
Phone+1 650-723-5791
Is this information wrong?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Endocrinology, 1980 - 1984
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1977 - 1980
University of California San Diego School of MedicineClass of 1977
University of CaliforniaB.S., Electrical Engineering, Highest Honors, 1969 - 1973

Certifications & Licensure

CA State Medical License 1978 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

America’s Best Doctors 1999-2018
America's Top Doctors Castle Connolly, 2002-2014
Honoree San Francisco Juvenile Diabetes Research Foundation, 2009
Honoree Diabetes Society, 2008
Honorary Board of Directors Diabetes Society of Santa Clara Valley, 1988
Luetje-Stubbs Faculty Scholar 1988-1989, 1992
Engineering Council of Sacramento Valley Award 1973
Tau Beta Pi 1972
Phi Kappa Phi 1972
Kraft Scholarship Prize UCD, 1969
Join now to see all

Clinical Trials

TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
Recruiting
Treatment of Insulin Resistance in Hypertensive, Obese Adolescents Start of enrollment: 2006 Oct 01
Terminated
Not Applicable
Glaser Obesity Study Start of enrollment: 2003 Oct 01
Unknown status
Phase 2, Phase 3
Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit Start of enrollment: 2005 Oct 01
Completed
Not Applicable
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01
Completed
Phase 3
Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure Start of enrollment: 2007 Feb 01
Completed
Not Applicable
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" Start of enrollment: 2010 Aug 01
Completed
Phase 2
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Start of enrollment: 2013 Mar 01
Completed
Phase 2
Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol Start of enrollment: 2014 Mar 12
Completed
Not Applicable
Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use Start of enrollment: 2014 Aug 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

2 citations
Diabetic Ketoacidosis at Diagnosis in Youth with Type 1 Diabetes Is Associated with a Higher Hemoglobin A1c Even with Intensive Insulin Management.
Dessi P Zaharieva, Ananta Addala, Priya Prahalad, Franziska Bishop, Manisha Desai, Darrell M Wilson, David M Maahs, Victoria Y Ding, Korey K Hood, Bruce A Buckingham> ;Diabetes Technology & Therapeutics. 2024 Mar 1
2 citations
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals.
Alyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, Darrell M Wilson, Andrea K Steck, Jennifer L Sherr, Jason L Gaglia, Christine Bender, Sandra Lord, Carla J Greenbaum> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Dec 21
7 citations
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.
Darrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, David Scheinker, Andrea K Steck, Madhuri M Vasudevan, Siripoom V McKay, Jenn...> ;Diabetes Care. 2023 Mar 1
4 citations
Automation of a multiplex agglutination-PCR (ADAP) type 1 diabetes (T1D) assay for the rapid analysis of islet autoantibodies.
Felipe de Jesus Cortez, David Gebhart, Devangkumar Tandel, Peter V Robinson, David Seftel, Darrell M Wilson, David M Maahs, Bruce A Buckingham, Kevin W P Miller, Cheng...> ;SLAS Technology. 2022 Feb 1
5 citations
Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model De...
Gregory P. Forlenza, Tim Vigers, Cari Berget, Laurel H. Messer, Rayhan A. Lal, Marina Basina, David M. Maahs, Korey K. Hood, Bruce A. Buckingham, Darrell M. Wilson, R....> ;Diabetes Technology & Therapeutics. 2021 Dec 1
23 citations
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt J Griff...> ;JCI Insight. 2021 Nov 8
10 citations
A community-based, multi-level, multi-setting, multi-component intervention to reduce weight gain among low socioeconomic status Latinx children with overweight or obe...
Thomas N. Robinson, Donna M. Matheson, Darrell M. Wilson, Dana L. Weintraub, Jorge A. Banda, Lee M. Sanders, William L. Haskell, K. Farish Haydel, Kristopher Kapphahn,...> ;The Lancet. Diabetes & Endocrinology. 2021 Jun 1
19 citations
Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR.
Felipe de Jesus Cortez, David Gebhart, Peter V. Robinson, David Seftel, Narges Pourmandi, Jordan Owyoung, Carolyn R. Bertozzi, Darrell M. Wilson, David M. Maahs, Bruce...> ;Plos One. 2020 Nov 13
46 citations
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening
Laura M. Jacobsen, Laura E. Bocchino, Carmella Evans-Molina, Linda A. DiMeglio, Robin Goland, Darrell M. Wilson, Mark A. Atkinson, Tandy Aye, William E. Russell, John ...> ;Diabetologia. 2020 Mar 1
134 citations
One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System.
Rayhan A. Lal, Marina Basina, David M. Maahs, Korey K. Hood, Bruce A. Buckingham, Darrell M. Wilson> ;Diabetes Care. 2019 Dec 1
66 citations
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clin...
Michael J. Haller, S. Alice Long, J Lori Blanchfield, Desmond A. Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Susan Geyer, Megan V. Warnock, Jessica L. ...> ;Diabetes. 2019 Jun 1
11 citations
A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring.
Laura M. Nally, Nicholas Bondy, Jasmine Doiev, Bruce A. Buckingham, Darrell M. Wilson> ;Diabetes Technology & Therapeutics. 2019 Mar 30
177 citations
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes
Federica Vecchio, Nicola Lo Buono, Angela Stabilini, Laura Nigi, Matthew J. Dufort, Susan Geyer, Paola M.V. Rancoita, Federica Cugnata, Alessandra Mandelli, Andrea Val...> ;JCI Insight. 2018 Sep 20
26 citations
Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverag...
Priya Prahalad, Ananta Addala, Bruce A. Buckingham, Darrell M. Wilson, David M. Maahs> ;Diabetes Technology & Therapeutics. 2018 Sep 1
91 citations
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
Michael J. Haller, Desmond A. Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica L. Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Lind...> ;Diabetes Care. 2018 Sep 1
16 citations
Predictive hyperglycemia and hypoglycemia minimization: In‐home double‐blind randomized controlled evaluation in children and young adolescents
Gregory P. Forlenza, Dan Raghinaru, Faye Cameron, B. Wayne Bequette, H. Peter Chase, R. Paul Wadwa, David M. Maahs, Emily Jost, Trang T. Ly, Darrell M. Wilson, Lisa M....> ;Pediatric Diabetes. 2018 May 1
1 citations
50 Years Ago in The Journal of Pediatrics: Familial Holoprosencephaly with Endocrine Dysgenesis.
Maria Chang, Darrell M. Wilson, David M. Maahs> ;The Journal of Pediatrics. 2018 Jan 1
20 citations
Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials.
Brandon M. Nathan, David Boulware, Susan Geyer, Mark A. Atkinson, Peter G. Colman, Robin Goland, William E. Russell, John M. Wentworth, Darrell M. Wilson, Carmella Eva...> ;Diabetes Care. 2017 Nov 1
17 citations
Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes
Tamara Spaic, Marsha Driscoll, Dan Raghinaru, Bruce A. Buckingham, Darrell M. Wilson, Paula Clinton, H. Peter Chase, David M. Maahs, Gregory P. Forlenza, Emily Jost, I...> ;Diabetes Care. 2017 Jan 18
147 citations
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
El-Khatib Firas H, Courtney A. Balliro, Mallory A. Hillard, Kendra L. Magyar, Laya Ekhlaspour, Manasi Sinha, Debbie Mondesir, Aryan Esmaeili, Celia Hartigan, Michael J...> ;Lancet. 2017 Jan 28
24 citations
Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes
Peter Calhoun, Bruce A. Buckingham, David M. Maahs, Irene Hramiak, Darrell M. Wilson, Tandy Aye, Paula Clinton, Peter Chase, Laurel H. Messer, Craig Kollman, Roy W. Be...> ;Journal of Diabetes Science and Technology. 2016 May 20
31 citations
Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Di...
KeenanD. Barry, RoyAnirban, HanJino, GrosmanBenyamin, CantwellMartin, KurtzNatalie, von EybenRie, ClintonPaula, M WilsonDarrell, A BuckinghamBruce> ;Diabetes Technology & Therapeutics. 2016 Jun 3
18 citations
Outpatient Care Preceding Hospitalization for Diabetic Ketoacidosis
Stephanie S. Crossen, Darrell M. Wilson, Olga Saynina, Lee M. Sanders> ;Pediatrics. 2016 Jun 1
8 citations
In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes.
Laurel H. Messer, Peter Calhoun, Bruce A. Buckingham, Darrell M. Wilson, Irene Hramiak, Trang T. Ly, Marsha Driscoll, Paula Clinton, David M. Maahs> ;Pediatric Diabetes. 2017 Aug 1
54 citations
Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes.
Paul K. Mazaika, Stuart A. Weinzimer, Nelly Mauras, Bruce A. Buckingham, Neil H. White, Eva Tsalikian, Tamara Hershey, Allison Cato, Tandy Aye, Larry A. Fox, Darrell M...> ;Diabetes. 2016 Feb 1
Join now to see all

Journal Articles

Reactivation of Latent Viruses in Individuals Receiving Rituximab for New Onset Type 1 Diabetes
Kroll JL, Beam C, Li S, Viscidi R, Pescovitz M, Weinberg A, the Type 1 Diabetes TrialNet Anti CD-20 Study Group, J Clin Virol, 2/17/2013
Epstein Barr and other Herpes Virus Infections in Early Onset Type I Diabetics Treated with Daclizumab and Mycophenolate Mofetil
Loechelt BJ, Boulware D, Green M, Baden LR, Gottlieb P, Krause-Steinrauf H, Weinberg A; for the Type I Diabetes TrialNet Daclizumab/Mycophenolic Acid Study Group, Clin Infect Dis, 10/5/2012
The Landmark JDRF Continuous Glucose Monitoring Randomized Trials: a Look Back at the Accumulated Evidence
Ruedy KJ, Tamborlane WV, for the Juvenile Diabetes Research Foundation The Landmark JDRF Continuous Glucose Monitoring Study Group, J of Cardiovasc Trans Res, 8/1/2012
Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High Risk Population - Receiver Operating Characteristic Analysis
Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP and the DPT-1 Study Group, Diabetes Care, 7/11/2012
The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes
Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP, The Type 1 Diabetes TrialNet And Diabete..., Diabetes Care, 7/1/2012
Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes
Tsalikian E, Fox L, Weinzimer S, Buckingham B,, White NH, Beck R, Kollman C, Xing D, Ruedy K and the Diabetes Research in Children, Pediatric Diabetes, 6/1/2012
Achievement of Target A1c Levels with Negligible Hypoglycemia and Low Glucose Variability in Youth with Short-Term Type 1 Diabetes and Residual beta-cell function
Sherr J, Tamborlane WV, Xing D, Tsalikian E, Mauras N, Buckingham B, White NH, Arbelaez AM, Beck RW, Kollman C, Ruedy K, On Behalf Of The Diabetes Research In Children..., Diabetes Care, 4/1/2012
Rituximab Selectively Suppresses Specific Islet Antibodies
Yu L, Herold K, Lachin J, Bundy B, Pugliese A, Krischer J, Eisenbarth G, Pescovitz M, Type 1 Diabetes TrialNet Anti-CD20 Study Group, Diabetes, 1/1/2012
Fall in C-peptide Over First Two Years from Diagnosis: Evidence of At Least Two Distinct Phases from Composite TrialNet Data
Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM, Type 1 ..., Diabetes, 1/1/2012
Performance of Glycated Hemoglobin (HbA1c) as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth
Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers M, Schatz DA, Krischer JP, and the TEDDY, TRIGR, Diabetes Prevention Trial-Typ..., Diabetes Care, 1/1/2012
A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 ...
Mauras, N Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, White NH, Weinzimer SA, Tamborlane W, Kollman C and the Diabetes Research In Children Network (DirecNet) Stu..., Diabetes Care, 12/30/2011
Effect of Rituximab on Human In Vivo Antibody Immune Responses
Pescovitz MD, Torgerson TR, Ochs HD, Ocheltree E, McGee P, Krause-Steinrauf H, Lachin JM, Canniff J, Greenbaum C Herold KC, Skyler JS, Weinberg A and the Type 1 Diabet..., J Allergy Clin Immunol, 12/1/2011
Comparison of Two Insulin Assays for First-Phase Insulin Release in Type 1 Diabetes Prediction and Prevention Studies
Mahon JL, Beam CA, Marcovina SM, Boulware DC, Palmer UP, Winter William E, Skyler JS, Krischer JP and the Type 1 Diabetes TrialNet Study Group, Clinica Chimica Acta, 11/20/2011
A Longitudinal Study of GAD65 and ICA512 Autoantibodies during the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) Participants
Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Cuthbertson D, Yu L, Schatz DA, Orban T, Eisenbarth G, Diabetes Prevention Trial-Type 1 and Type 1 Diabetes TrialNet Stu..., Diabetes Care, 11/1/2011
Development of Autoantibodies in the TrialNet Natural History Study (NHS)
Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP for the TrialNet Natural History Study Group, Diabetes Care, 9/1/2011
Increased T Cellular Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (Rituximab) Therapy in Type 1 Diabetes
Herold K, Pescovitz M, McGee P, Krause-Steinrauf H, Spain L, Bourcier K, Asare A, Liu Z, Lachin J, Dosch HM, for the Type 1 Diabetes TrialNet Study Group, J Immunology, J Immunol, 8/15/2011
Long-Term Outcome of Individuals Treated With Oral Insulin
Vehik K, Cuthbertson D, Ruhlig H, Schatz DA, Peakman M, Krischer JP For The DPT-1 And TrialNet Study Group, Diabetes Care, 7/1/2011
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study
Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP; the TrialNet and Diabetes Prevention Tri..., Diabetes Care, 6/16/2011
Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for Repeat Screening Throughout Childhood
Vehik K, Haller MJ, Beam CA, Schatz DA, Wherrett DK, Sosenko JM, Krischer J, the DPT 1 Study Group, Diabetes Care, 1/1/2011
Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes
Tansey M. Laffel L, Cheng J, Beck R, Coffey J, Huang E, Kollman C, Lawrence J, Lee J, Ruedy K, Tamborlane W, Wysocki T, Xing D on behalf of Juvenile Diabetes Research ..., Diabet. Med, 1/1/2011
Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Diabetes
Lachin JM, McGee PL, Greenbaum CJ, Palmer J, Pescovitz MD, Gottlieb P, Skyler J for the Type 1 Diabetes TrialNet Study Group, PLOS One, 1/1/2011
Insulin Pump Use and Its Efficacy in Preschool Aged Children
Fuld K, Conrad B, Buckingham BA, Wilson DM, Diabetes Technology & Therapeutics, 6/1/2010
The cost-effectiveness of continuous glucose monitoring in type 1 diabetes
Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T; Juvenile Diabetes Research Foundation Continu..., Diabetes Care, 6/1/2010
Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Non-diabetic Individuals
The Juvenile Diabetes Research Foundation CGM Study Group,, Care, 6/1/2010
A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants
Sosenko JM, Mahon J, Rafkin L, Lachin JM, Krause-Steinrauf H, Krischer JP, Cuthbertson D, Palmer JP, Thompson C, Greenbaum CJ, Skyler JS; Diabetes Prevention Trial-Typ..., Pediatr Diabetes, 5/26/2010
Join now to see all

Books/Book Chapters

Endocrine disorders
Chapter: A Practical Guide to Pediatric Emergency Medicine
Forghani N, Wilson DMEditors: Amieva-Wang et al.Cambridge Press2011
A Practical Guide to Pediatric Emergency Medicine
Chapter: Neonatal emergencies, Chapter 157
Park JG, N. Amieva-Wang E, Turchi C, Forghani N, and Wilson DMEditors: Amieva-Wang et al.Cambridge Press2011
Real-time continuous glucose monitoring
Buckingham B, Caswell K, Wilson DM2007
Contemporary Endocrinology: Hormone Replacement Therapy in Clinical Practice
Chapter: Growth hormone therapy in children and adult
Wilson DMEditors: Meikle AW.Humana Press Inc., Toronto, NJ2003
Contemporary Endocrinology: Hormone Replacement Therapy
Chapter: Growth hormone therapy in children
Lum CK, Wilson DMEditors: Meikle AW.Humana Press Inc., Toronto, NJ1999
Nelson Self-Assessment Program
Chapter: Diabetes mellitus
Wilson DMEditors: Prober CG, Behrman RE, Cisco J.WB Saunders1995
UPDATE #8 - Nelson's Textbook of Pediatrics
Chapter: Diabetes Mellitus in Children and Adolescents
Wilson DM1995
Frontiers in Rehabilitation Medicine: Osteogenesis Imperfecta, Connective Tissue Research
Chapter: Endocrinology of growth and growth factors
Wilson DMEditors: Gerber L, Byers P, Marini J.1995
Fundamentals of Pediatrics
Chapter: Pediatric Endocrinology
Rosenthal S, Wilson DMEditors: Appleton & Lange.Norwalk, CT1994
Puberty... When it comes too soon. A Special Ross Round table on Pediatric Research, Conference in Washington, DC
Chapter: Indications for Treatment
Hintz RL, Wilson DMEditors: Hintz RL, Wilson DM.Ross Products Division, Abbott Laboratories, Columbus, OH1994
Phosphate in Pediatric Health and Disease
Chapter: Renal hypophosphatemia
Page 159 - 192Wilson DM, Alon UEditors: Alon U, Chan JCM.CRC Press, Boca Raton, FL1993
Endocrinology and Metabolism Clinics of North America
Chapter: Clinical Actions of Growth Hormone
Page 519 - 537Wilson DM1992
Turner syndrome
Chapter: Effects of growth hormone and oxandrolone therapy on carbohydrate metabolism in Turner syndrome
Page 433 - 445Wilson DM, Hintz RL, Rosenfeld RG, Frane JW, Sherman B, Johanson AJEditors: Rosenfeld RG, Grumbach M.Marcel Dekker, Inc, NY1990
Advances in Endocrinology and Metabolism
Chapter: New directions in the diagnosis and treatment of growth failure
Page 95 - 128Wilson DM, Rosenfeld RGEditors: Mazzaferri E, Bar RS, Kreisberg RA.1990
Highlights of the 3rd International Symposium on Endocrine Disorders
Chapter: Hypophosphatemic rickets
Page 16 - 17Wilson DMEditors: Rosenfeld RG.Excerpta Medica1990
Insulin-like Growth Factor Binding Proteins
Chapter: Serum levels of 25Kda insulin-like growth factor binding in children with insulin-dependent diabetes mellitus
Page 39 - 44Wang M, Wilson DM, Lee PDKEditors: Hintz RL.Elsevier Science Publishers, Amsterdam1989
Insulin-like Growth Factor Binding Proteins
Chapter: IGFs and IGF binding proteins in human breast cancer cell lines
Page 241 - 246Wilson DM, DeLeon DD, Bakker B, Lamson G, Rosenfeld RGEditors: Hintz RL.Elsevier Science Publishers, Amsterdam1989
Disorders of Human Growth: Advances in Research and Treatment
Chapter: Use of somatomedin assays in the evaluation of short stature. NICHD International Workshop on Advances in Research of Human Growth
Page 82 - 95Rosenfeld RG, Wilson DM, Lee PDK, Hintz RLEditors: Grave GD, Cassorla FG.Thomas, Springfield, IL1988
Future Clinical Use of Growth Hormone, Series Pediatric and Adolescent Endocrinology
Chapter: Usefulness of somatomedin C/Insulin-like growth factor levels and response in growth hormone deficiency
Page 29 - 36Hintz RL, Wilson DM, Rosenfeld RGEditors: Laron Z, Butenandt O.S Karger1987
Acromegaly
Chapter: Somatomedin action and tissue growth factor receptors
Page 55 - 64Rosenfeld RG, Ceda GP, Conover CA, Wilson DM, Hoffman AREditors: Robbins R, Melmed S.Plenum Press, NY1987
Slow Grows the Child: Psychosocial Aspects of Growth Delay
Chapter: The effects of growth on intellectual function in children and adolescents
Page 139 - 150Wilson DM, Duncan PM, Dornbusch SM, Ritter PL, Rosenfeld RGEditors: Stabler B, Underwood LE.Lawrence Erlbaum Associates, NJ1986
Somatomedins and Other Peptides Growth Factors: Relevance to Pediatrics
Chapter: Clinical relevance of the somatomedins
Page 64 - 69Rosenfeld RG, Wilson DM, Lee PDK, Hintz RLEditors: Hintz RL, Underwood LE.Ross Laboratories1985
Hormone Drug Proceedings of the FDA USP Workshop on Drug and Reference Standards for Insulins, Somatotropins, and Thyroid axis Drugs
Chapter: Recombinant DNA derived growth hormone is biologically active in humans: In vitro and in vivo studies
Page 352 - 362Rosenfeld RG, Wilson DM, Bennett A, Hintz RLEditors: JL Guerigan, ED Branson, AS Outschoorn.USPC, Rockville, MD1982
Growth Abnormalities, Contemporary Issues in Endocrinology and Metabolism
Chapter: Growth abnormalities in diabetes mellitus
Page 59 - 80Wilson DMEditors: Hintz RL, Rosenfeld RG.Churchill Livingstone, Inc
Join now to see all

Abstracts/Posters

Glucose simulators: Ready for Prime Time? (editorial)
Wilson DM, Diabetes Technology & the 2013 American Control Conference, Therapeutics, Washington, DC, USA, 1/1/1999

Other

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
DirecNet (Wilson DM)
1/1/2007
Book review JAMA, Preventing Childhood Obesity: Health in the Balance
Wilson DM
1/1/2006
Book review. Diabetes,: Nestle Nutrition Workshop Series
Wilson DM
1/1/1996
Abnormal growth patterns in children
Wilson DM, Rosenfeld RG
3/1/1988
Therapeutic goals in children with diabetes
Wilson DM
4/1/1987
Join now to see all

Press Mentions

Clinical Startup of the 670G Closed Loop Insulin Delivery System (670Gstartup)January 7th, 2017

Grant Support

Type 1 Diabetes Trialnet At StanfordNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Clinical Trial: Type 1 Diabetes: Cellcept Alone Or In Combination With DaclizumaNational Center For Research Resources2008
Clinical Trial: Trialnet Screening To Assess Risk Of Type 1 DiabetesNational Center For Research Resources2008
Clinical Trial: Trial Of Metformin In Obese Adolescentsmetformin In Obese AdolNational Center For Research Resources2008
Clinical Trial: Shared Diabetes Trial StudiesNational Center For Research Resources2008
Clinical Trial: Rituximab On The Progression Of Type 1 Diabetes In New Onset SubNational Center For Research Resources2008
Clinical Trial: Oral Insulin In Relatives At Risk For Type I Diabetes MellitusNational Center For Research Resources2008
Type 1 Diabetes: Cellcept Alone Or In Combination With DaclizumabNational Center For Research Resources2007
Trial Of Metformin In Obese AdolescentsNational Center For Research Resources2007
Recent Onset Type-1 Diabetes Mellitus Study Of Using Fresh Blood SamplesNational Center For Research Resources2007
Effects Of Rituximab On The Progression Of Type 1 DiabetesNational Center For Research Resources2007
Trialnet Screening To Assess Risk Of Type 1 DiabetesNational Center For Research Resources2005–2007
Shared Diabetes Trial StudiesNational Center For Research Resources2004–2007
Trialnet Screening To Assess Risk Of Type-1 DiabetesNational Center For Research Resources2006
Improving Metabolic Assessments In Type-1 Diabetes Mellitus Clinical TrialsNational Center For Research Resources2006
Immunotherapy For New Onset Type-1 DiabetesNational Center For Research Resources2006
Blood Samples From Subjects With Recent Onset Type-1 Diabetes MellitusNational Center For Research Resources2006
Metformin In Obese AdolescentsNational Center For Research Resources2005–2006
Type I Diabetes Trialnet At StsnfordNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
Immunotherapy For New Onset Type 1 DiabetesNational Center For Research Resources2005
A Diabetes Prevention Trial For Type I Diabetes [Dpt-1]National Center For Research Resources2005
Multicenter Intervention Trial To Prevent IDDNational Center For Research Resources2004
A Multi-Center, Randomized, Placebo-ControlledNational Center For Research Resources2004
Type I Diabetes Trialnet At StanfordNational Institute Of Diabetes And Digestive And Kidney Diseases2001
Near-Continuous Glucose Monitoring In PediatricsEunice Kennedy Shriver National Institute Of Child Health &Human Development2001
Intensive Insulin Regimen For Type I Diabetes MellitusNational Center For Research Resources2000–2001
Improved Monitoring Of GNRH Analog TherapyNational Center For Research Resources2000–2001
Multicenter Intervention Trial To Prevent Insulin-Dependent Diabetes MellitusNational Center For Research Resources1996–2001
Noninvasive Optical Glucose Detection Of Human FluidsNational Center For Research Resources1998–1999

Hospital Affiliations

Lucile Packard Children's Hospital StanfordPalo Alto, California